Safety and efficacy of non-vitamin K antagonist oral anticoagulants compared to warfarin in patients with atrial fibrillation and end stage renal disease: a meta-analysis of randomized trials

Back

ESC Professional Premium Access

Safety and efficacy of non-vitamin K antagonist oral anticoagulants compared to warfarin in patients with atrial fibrillation and end stage renal disease: a meta-analysis of randomized trials

Session: Atrial fibrillation stroke prevention with oral anticoagulants in difficult cases

Topic: Oral Anticoagulation

Speaker: Doctor T. Chao (Taipei, TW)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Tze-Fan Chao

Taipei Veterans General Hospital, Taipei (Taiwan)

4 presentations

0 follower

7 more presentations in this session

Anticoagulation-associated bleeding in patients randomised to screening for atrial fibrillation or usual care

Speaker: Doctor E. Kongebro (Copenhagen, DK)

Safety and efficacy of anticoagulation for atrial fibrillation in cirrhotic patients

Speaker: Doctor J. Song (Los Angeles, US)

Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year follow-up of more than 13,000 patients from the ETNA-AF-Europe study

Speaker: Professor R. De Caterina (Pisa, IT)

Anticoagulation therapy in patients with atrial fibrillation and active cancer

Speaker: Doctor J. Jaakkola (Turku, FI)

Individual risk prediction of anticoagulation in atrial fibrillation patients with cirrhosis

Speaker: Assistant Professor I. Kim (Seoul, KR)

Access the full session

Atrial fibrillation stroke prevention with oral anticoagulants in difficult cases

Speakers: Doctor T. Chao, Doctor E. Kongebro, Doctor J. Song, Professor R. De Caterina, Doctor J. Jaakkola...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources